Amgen’s Prolia™ (denosumab) Was Approved By FDA
On June 1, 2010, Amgen inc. announced, that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women…
On June 1, 2010, Amgen inc. announced, that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women…